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Purpose 
This information is specifically intended to assist veterinarians in the safe management of 
incidents involving contact between domestic animals (cats or dogs) and bats with the resulting 
potential for these animals to acquire Australian Bat Lyssavirus infection (ABLV). 
Scope 
This information is intended for use by veterinarians to help them manage the situation when a 
member of the public presents a dog or cat with a clinical history of actual or suspected physical 
encounter with a bat. It provides information that relates to: 
• Australian bat lyssavirus disease and epidemiology
• practical information for handling bats and submitting for laboratory testing
• the options to be presented to the pet owner if the bat is not available or tests positive for
ABLV
• the use of inactivated rabies vaccine to protect the pet, including the associated permit, Chief
Veterinary Officer (CVO) authorisation and evaluation of the response to vaccination.
Reference information 
General 
ABLV is a member of the genus Lyssavirus, family Rhabdoviridae. The Lyssavirus genus contains 
seven genotypes of which ABLV has been placed in a distinct group - Genotype 7. While closely 
related to classical rabies virus (Genotype 1), ABLV is distinct from it. 
Consequently Australia has a current international health status through the World Organisation for 
Animal Health (OIE) of ‘rabies-free’. However, wherever specific information on the epidemiology  
of ABLV is lacking, classical rabies is used as a model. 
ABLV was first identified in 1996 by researchers at the Queensland Government Animal Research 
Institute following isolation of the virus from samples collected from a black flying fox which had 
been found sick at Ballina. It has since been found in several species of Australian flying foxes and 
insectivorous bats over a wide geographic distribution. 
ABLV is a recognised zoonosis and human health is an overriding factor in all incidents involving 
potential ABLV infection of pet animals and their owners. 
There have been three recorded cases of fatal encephalitis due to ABLV in people: in 1996 and 
1998, both in Queensland. Both had a history of exposure to bites or scratches from bats; one 
case was caused by a flying fox (a megabat) and the other by a yellow-bellied sheath-tail bat (a 
microbat). 
National policy 
National policy and approach to ABLV is presented in the AUSVETPLAN disease strategy 
for ABLV. Comprehensive information is provided for the management of animals that have 
potentially been infected with ABLV. 
It is presumed that, if an animal of a non-bat species develops clinical disease due to ABLV 
infection, that animal has the potential to transmit ABLV to humans and other animals. 
This document provides information based on AUSVETPLAN for the management of bat/animal 
incidents in Queensland. 
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Categories of risk 
Bats can be categorised based on their potential to transmit ABLV to humans and 
other animals (i.e. potential for an infected bat to have infectious contact with a 
human or other animal). These categories are listed from highest to lowest urgency for action: 
Category 3 (high human health risk). Bat that is known or reasonably 
suspected to have had potentially infectious contact with a human (e.g. has 
bitten or scratched a person). Within Category 3, bats with clinical signs 
suggestive of ABLV are of highest risk. 
Category 2 (high animal health risk, medium human health risk). Bat that 
poses a potential risk of infection to humans. Disease investigation and 
exclusion testing is recommended due to either: 
– history or clinical signs suggestive of ABLV without a history of a
potentially infectious contact with a human (Category 2a) 
– history of known or suspected contact with another animal (other animal
potentially exposed to ABLV via bat) (Category 2b). 
Category 1 (low risk). Bat that is neither Category 2 nor Category 3 — that is, 
bat that has no history of known or suspected contact with another animal or 
person and for which the index of suspicion for ABLV infection is low (e.g. no 
clinical signs consistent with ABLV). 
Legal considerations 
ABLV is listed as category 1 restricted matter in schedule 2 of the Biosecurity Act 2014 (the Act). 
The Act requires a person who knows or suspects clinical disease due to ABLV infection to advise 
an inspector as soon as practicable but within 24 hours. A person does not need to advise of a 
suspicion of ABLV simply by virtue of the animal being a bat, or if the animal (e.g. a dog) has simply 
had contact with a bat.  
However, if a person believes or ought to believe that a bat or other mammal is infected with ABLV 
(e.g. due to clinical signs or behavioural changes suggestive of ABLV), they must advise an 
inspector and take all reasonable and practical measures to prevent or minimise the risk of 
transmission to a person or other animal. The current APVMA (Australian Pesticides and Veterinary 
Medicines Authority) permit, PER14236, indicates the permitted use of rabies vaccine in Australia. 
Epidemiology 
To date, the natural reservoir of ABLV in Australia remains bats - no other reservoir in Australia 
has been detected. Serological evidence suggests a wide geographical distribution in bats in 
Australia (Field 2005 quoted in AUSVETPLAN ABLV disease Strategy Manual Section 1.3.2). 
ABLV has been found in both the megabat species (flying foxes) and the microbat species in 
Australia; antibodies to ABLV have been found in five of the six families of bats in Australia 
(surveillance of the sixth family was limited), and all individual bats should be regarded as capable 
of being infected and infectious. 
Bats showing clinical disease caused by ABLV can present with a range of non-specific clinical 
signs that may include one or more of the following: 
• Overt aggression,
• Paresis and paralysis
• Seizures, tremors and weakness
• Respiratory difficulties, change of voice
• On ground or low in a tree with inability to take off or to fly in a normal manner
• Bats in unusual locations during the daytime. i.e not in normal roosts
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Based on testing to date, there is a much higher likelihood of finding ABLV in sick, injured or 
orphaned bats (5 - 10%) compared to the normal wild population (< 1%). Of bats that are sick or 
can’t fly, ABLV may be found in up to 30% of those showing central nervous system signs. 
ABLV is a zoonotic disease and has been confirmed as causing the death of two people. There is 
no field evidence in Australia to date that demonstrates that ABLV infection naturally occurs in 
other mammals, except bats and man. 
Research on ABLV has not yet addressed whether it is possible for the reservoir host (bats) to 
infect other mammals (except man) and for those animals to go on to infect other animals so there 
is no current evidence to say that ABLV could or could not spill over to terrestrial species and then 
be transferred on to humans. 
A preliminary study conducted at the Australian Animal Health Laboratory (AAHL) in which dogs 
and cats were experimentally infected with ABLV was inconclusive. The animals sero-converted 
but did not demonstrate overt clinical disease during the (short) duration of the study. It is not clear 
how much these results can be extrapolated to natural infection of animals (AUSVETPLAN ABLV 
Disease Strategy Manual, Section 1). 
There are documented reports overseas of spillovers of bat-variant rabies and European bat 
lyssaviruses to terrestrial species. 
There is no effective treatment for ABLV once clinical signs are observed. Prevention of clinical 
disease is the preferred option through pre-exposure vaccination or post exposure prophylaxis. 
Both these approaches revolve around the use of rabies vaccine. 
An important observation is that ABLV-infected bats have a higher likelihood of being present 
much closer to the ground than normal and with less ability to fly to safe areas when challenged. 
Consequently any bat-animal (including pets) interaction is potentially serious as these animals are 
interacting with the sub-population of bats where there is the greatest likelihood of finding ABLV. 
Reports are regularly received by Biosecurity Queensland of domestic pets, particularly dogs or 
cats, coming into close physical contact with bats, for example, through chasing and catching bats 
and/or ingestion of bats. This close contact forms a theoretical risk of transmission of ABLV to 
dogs and cats and, theoretically, to their owners. Currently this chain of transmission is rated as 
remote, but possible. 
Actions following an animal bat exposure 
Notify Biosecurity Queensland 
There is a legal requirement to notify Biosecurity Queensland of all suspected ABLV incidents 
(see section 3.4). 
Please contact: 
• 13 25 23 (business hours)
• 1800 675 888 (any time)
• a Biosecurity Queensland veterinary officer.
Biosecurity Queensland takes a precautionary approach to potential exposures to ABLV while 
scientific knowledge continues to be accumulated. This precautionary approach assumes that 
possible exposures between animals and bats may transmit ABLV to the in-contact animals. 
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Further it is assumed that an animal infected with ABLV may progress to develop rabies-like 
clinical disease and may then pose a risk of transmitting ABLV to humans and other animals. 
Obtain the history 
Details should be obtained about the incident when the client’s animal came in contact with the bat. 
Any observations about the clinical condition of the bat should be recorded. If the bat appeared ill 
at the time of the incident it is more likely to be infected with ABLV. Clinical signs associated with 
ABLV infection of bats are described in section 3.5. 
It should also be established whether the bat is dead or still alive. If still alive it becomes a priority 
to provide advice on safe handling and personal protection. 
If the client reports that they themselves have been scratched or bitten by a bat, Queensland 
Health must be informed of this potential exposure to ABLV. 
Reporting potential human exposure to Queensland Health 
When a human/bat interaction has occurred, the people involved should be advised to immediately 
ring their local Population Health Unit (see Appendix 1). 
These bats are described as C3 (Risk Category 3). 
Advice should be provided to isolate the bat or avoid further contact and to wash the affected area 
with soap and water (see section 4.4.4). 
If the bat is available it should be safely kept for testing. Queensland Health is responsible for 
testing C3 bats. 
Retrieval and euthanasia of the bat 
The advantage of testing the bat for ABLV is that a negative result will exclude the risk of ABLV 
transmission to other animals or humans. 
Testing is best conducted on the brain tissue, so it is important to retrieve the head. However other 
nervous tissue may be useful. Therefore whatever is left of the bat should be submitted. 
People are at risk of contracting ABLV if they handle bats without due precautions. Rabies virus 
and other lyssaviruses are usually transmitted to humans via bites or scratches which provide 
direct access of the virus in saliva to exposed tissue and nerve endings. Exposure to virus in bat 
saliva via mucous membranes (eyes, nose, mouth) and open wounds (bites, sores) can also occur. 
Handling a dead bat 
If the bat is dead, it should be collected and placed inside a secure and waterproof container. 
Exposure of skin or mucous membranes to the secretions or excretions of the bat must be 
avoided. Handling the carcass remotely (e.g. using a garden fork, spade or other implement), 
inverting a thick plastic bag over the carcass, and using rubber gloves are recommended methods 
of preventing direct exposure. 
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Handling a live bat 
Live bats should only be handled by people who have received rabies vaccination. 
Members of the public are strongly advised not to attempt to handle an injured, unwell or 
aggressive bat. They should contact a Department of Environment and Heritage Protection  
(DERM) registered bat carer who can then transport these bats to a private veterinarian who 
normally deals with wildlife. Subject to the veterinarian’s assessment of possible ABLV, the bat can 
then be euthanased before being submitted to a veterinary laboratory for testing. 
AUSVETPLAN states that ‘Animals potentially infected with Australian bat lyssavirus should be 
approached with extreme caution. ….Only experienced bat handlers who have been vaccinated 
for rabies should attempt to capture and care for sick or injured bats’. 
The following precautions should be taken when handling bats: 
• Only vaccinated people with titres >0.5IU/ml should handle bats
• Take all reasonable steps to avoid being bitten or scratched
• Prevent mucous membrane exposure (eyes/mouth)
• Wear appropriate protective clothing, long sleeves, long pants, shoes and double gloves
(nitrile – puncture resistant)
• Where possible have a vaccinated, experienced bat handler hold the bat when conducting a
clinical examination or euthanasia.
Useful contact details include: 
• Department of Environment and Heritage Protection   http://www.ehp.qld.gov.au /
Euthanasia of a bat 
Bats can be euthanased using pentobarbitone solution injected intra-peritoneally. 
Storage or disposal of a bat carcass 
Carcasses of bats to be tested should be submitted to the laboratory as soon as practicable to 
minimise post-mortem decomposition. 
Whether collected as dead or euthanased, these carcasses should be refrigerated (but not frozen) 
until submission. 
If a client elects not to submit a dead bat for testing, the carcass must be disposed of hygienically, 
either in routine clinic biological waste, deep burial where dogs cannot dig them up, or submitted to 
a special local council service that may be available. 
Emergency measure if bitten or scratched by a bat 
If bitten or scratched, proper cleansing of the wound is the single most effective measure for 
reducing transmission: 
• Do not scrub the wound.
• The wound should be immediately washed with soap and water for at least 5 minutes.
• An antiseptic with anti-viral action, such as povidine-iodine, iodine tincture, aqueous iodine
solution or alcohol (ethanol) should be applied after washing.
• If saliva enters the eyes, nose or mouth, the area should be flushed thoroughly with water.
• Contact your Doctor or Queensland Health immediately (see Appendix 1 for contact details).
Laboratory testing 
In cases of known or probable exposure of an animal to a bat (C2 bat) or where a bat shows 
clinical signs suggestive of ABLV, submission of the bat for ABLV exclusion testing should be to a 
Biosecurity Queensland laboratory. 
Where there has been known, possible or probable human exposure to ABLV from the bat (C3  
bat), submission of the bat must be to the Queensland Health laboratory and needs to be arranged 
through contacting the relevant Queensland Population Health Unit (contact details in Appendix 1). 
The standard test for ABLV in a bat submitted after an animal/bat incident is the fluorescent 
antibody test (FAT). This is ideally conducted on fresh brain impressions. However, other nervous 
tissue can be used if the head of the bat is not available. 
Other tests may be used during research or to type the ABLV virus. 
Submission of the bat for testing 
Packaging and transport of dead bats does not require a permit from EHP but any such transport 
does need to meet relevant transport and packaging guidelines. 
Samples can be delivered to the Specimen Receipt office at Coopers 
Plains between 8am and 5pm on weekdays. The delivery address is: 
Specimen Receipt (Loading Dock 12) 
Biosecurity Sciences Laboratory 
Health and Food Science Precinct 
39 Kessels Road 
Coopers Plains Qld 4108 
The BSL phone number is 07 3708 8762 
Email address: bslclo@daf.qld.gov.au. 
If the incident occurs out of hours, people should contact the Emergency Animal Disease Hotline 
on 1800 675 888 to arrange testing. 
Packaging instructions for sending bats include: 
• Ensure safety of all personnel involved.
• Samples must be double-bagged.
• The bat must be in a secure primary container such as a strong polythene bag. Then place in
a secondary container, a screw top plastic container or a zip lock bag.
• Use absorbent material in the secondary container to soak up any leaked fluid.
• Place the secondary container in a polystyrene box with cold bricks.
• Complete a specimen advice sheet (SAS) which can be downloaded from the Website
www.biosecurity.qld.gov.au
• Place the SAS on the outside of the polystyrene box so it can be read before the samples are
opened.
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Actions if the bat tests negative for ABLV 
When the bat tests negative for ABLV, there is no risk to the in-contact animal and the case is 
closed. 
Situations have occurred where the animal may have been bitten by more than one bat. Therefore 
the risk of exposure may not be resolved by the testing of only one bat. In this situation the 
veterinarian may decide to proceed according to section 6. 
Actions if the bat tests positive for ABLV or is not 
available 
If the bat is available and tests positive or is not available for testing, this means that there is a real 
risk of the pet owners or other in-contact humans contracting ABLV infection from the pet. To date, 
transmission from an affected pet to a human has never been reported. Public health 
guidance is that the risk of transmission of ABLV from a dog or a cat to a person is very low but the 
risk exists. If such transmission was to occur, the potential outcomes are obviously extremely 
serious as both reported cases of ABLV infection in humans have been fatal. 
Advice to the owner should include the following options: 
Euthanasia 
To avoid any further risk of humans contracting ABLV infection from the pet, the owner has the 
option of authorising euthanasia of the pet (especially in those cases where it can be established 
that physical contact between the animal and the bat definitely occurred.) 
Monitor the animal for up to 2 years 
The pet owner can keep the animal at home but should be advised to observe their pet closely for 
one to two years for any changes in behaviour or signs of ill-health (due to the possible long 
incubation period). These should be immediately reported to Biosecurity Queensland. The owner 
needs to also understand that taking no action does nothing to lower the potential risk of ABLV 
infection and that, if clinical signs suggesting ABLV disease are reported, it is likely to be 
recommended that the animal be euthanased and samples taken for examination. 
Vaccination 
One option is a course of vaccination of the affected pet with inactivated rabies vaccine as soon as 
possible after the contact with the bat in order to mitigate the risks of clinical ABLV infection. This 
mirrors the current public health recommendation for post-exposure treatment of people against 
ABLV infection through the use of rabies vaccine on the basis of the limited available animal data 
and clinical experience supporting its use. 
For the costs associated with vaccination, please see section 8. 
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Vaccination of the animal with rabies vaccine 
General advice 
When a positive is received or when a bat is not available for testing, the owner is offered the 
option of vaccinating the animal/s with rabies vaccine. This is conditional on the understanding that 
Biosecurity Queensland will determine further action required should the animal/s develop clinical 
signs of ABLV infection at any time. 
It should be emphasised to the owner that, if they are considering the vaccination program, it 
should be commenced as soon as possible after the date of the incident during which exposure to 
the bat occurred. 
The incubation period for ABLV is thought to be of the order of 28 – 60 days but can be shorter or 
much longer. 
This primary objective of the Post-Exposure Prophylaxis (PEP) vaccination schedule is to address 
the risk of exposure to ABLV. The PEP protocol specified below will not reliably avert expression of 
clinical disease in the dog or cat until 21 days post vaccination. After day 21 post vaccination, 
however, it is expected to reliably avert expression of clinical disease in the dog or cat and, 
therefore, the risk of transmission to humans. However, it is recommended that owners monitor the 
animal closely for 60 days post-vaccination. 
Therefore, the earlier the vaccine is given to the dog or cat after the potential exposure to ABLV via 
the bat, the less likely the dog or cat is to develop the disease before the PEP protocol can take 
effect and lower the risk to both dog or cat and the humans associated with the animal. 
If the private veterinarian suspects ABLV infection of the animal/s at any time, Biosecurity 
Queensland should be urgently contacted for advice on the appropriate course of action. 
The owner is responsible for: 
• Observing the dog or cat closely for any changes in behaviour occurring for 60 days following
vaccination and return the animal to the veterinarian for examination should there be any 
concerns. 
• Presenting their animal to their private veterinarian at the required times to meet all the
requirements of the vaccination and sampling program. 
• Complying with the requirement to microchip the animal/s.
• Payment for the vaccine and first two vaccination consultations (see section 9).
Rabies vaccine 
Vaccination with vaccine protective against rabies is used to protect both people and animals 
against ABLV. From the AUSVETPLAN Australian Bat Lyssavirus Disease Strategy Section 1.5, 
information to date supports that cross protection occurs against ABLV from rabies vaccine. Both 
people and animals exposed or potentially exposed to ABLV should undergo post exposure 
prophylaxis (PEP) which centres on the use of rabies vaccine. Queensland Health is responsible 
for PEP in people; Biosecurity Queensland in conjunction with private veterinarians is responsible 
for PEP in animals. 
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Permit PER14236 
Veterinarians need to be aware that Nobivac Rabies Inactivated Rabies Vaccine is an unregistered 
veterinary chemical product. Its use in ABLV incidents is covered by an Emergency Use Permit, 
PER14236, issued by the Australian Pesticides and Veterinary Medicines Authority (APVMA) and 
held by the Australian Chief Veterinary Officer, Commonwealth Department of Agriculture, Fisheries 
and Forestry. 
PER14236 also covers emergency use of this inactivated rabies vaccine to vaccinate ‘animals held 
in Australia in the event of a rabies outbreak’. A condition of the permit is that ‘Persons who wish to 
prepare for use and/or use the products for the purposes specified in this permit must read, or 
have read to them, the permit particularly the information included in DETAILS OF PERMIT and 
CONDITIONS OF PERMIT’. 
A copy of PER14236 can be obtained from the APVMA web-site 
(http://permits.apvma.gov.au/PER14236.PDF). 
Application by veterinarian to obtain and use rabies vaccine 
The vaccination program must be administered by a private veterinarian registered in Queensland. 
The veterinarian must complete and submit the form “Application to Chief Veterinary Officer: For 
authorisation to use of Nobivac rabies inactivated rabies vaccine” (see Appendix 2). 
Authorisation by Chief Veterinary Officer 
PER14236 includes that veterinarians authorised in writing by the State/Territory Chief Veterinary 
Veterinary Officer (CVO). Biosecurity Queensland will provide the CVO authorisation for the nominated 
veterinarian after the veterinarian submits an application (refer Appendix 2). Once signed, a copy 
of the CVO authorisation will be faxed back to the nominated veterinarian. 
The veterinarian should then fax the signed authorisation to a veterinary wholesaler who holds an 
account with the Australian supplier of the unregistered Nobivac Rabies Inactivated Rabies 
Vaccine, Intervet (Australia) Pty Ltd. 
Procuring the inactivated rabies vaccine 
The unregistered Nobivac Rabies Inactivated Rabies Vaccine is available from the Australian 
supplier following presentation of the Chief Veterinary Officer authorisation. 
Intervet (Australia) Pty Ltd 
91-105 Harpin St 
Bendigo Victoria 3550 
Phone: 1800 033 461 
Fax: 1800 817 414. 
The order should be placed through the veterinarian’s usual veterinary wholesaler because Intervet 
has existing accounts for the wholesalers. The inactivated rabies vaccine will still be sent directly to 
the veterinary practice ordering it. 
The inactivated rabies vaccine will only be dispatched from Monday to Wednesday to ensure that 
the vaccine arrives at the destination practice in good condition by avoiding possible problems 
encountered during transport leading up to the weekend. 
The vaccine must be ordered before 1:00 pm Monday to Wednesday to ensure that it can be 
dispatched that evening. 
An overnight courier service is engaged but Intervet does not have control over the transportation 
and so is unable to guarantee next day delivery. It is therefore best to consider two days for 
delivery when making the appointment for the client to attend the practice for vaccination. 
The vaccination protocol, as set out below, requires two vaccinations 5 -7 days apart. Therefore, it 
is advisable to order both doses from Intervet (Australia) Pty Ltd at the outset. 
Safety when administering the vaccine 
The private veterinarian engaged to administer the inactivated rabies vaccine to the pet as well as 
any assistants are advised to wear suitable long-sleeved protective clothing and to use restraint 
measures as appropriate to avoid being bitten or scratched by the pet animal. 
Caution should also be exercised in relation to avoiding contamination of unhealed cuts or abraded 
skin. 
Vaccination protocol – Post-exposure Prophylaxis (PEP) 
At the first PEP consultation (day 0), the first dose of rabies vaccine is given to the animal/s. A 
blood sample should be taken, the serum removed to a vial and frozen. 
A repeat vaccination with rabies vaccine is given to the animal/s at day 5 – 7. 
A follow-up blood sample should be collected at day 28 post vaccination (or up until day 35) and 
the serum again collected and frozen. The paired sera will be submitted to the Biosecurity Sciences 
Laboratory for forwarding to the Australian Animal Health Laboratory (AAHL). 
The instructions for submitting the serum samples are: 
• The standard Specimen Advice Sheet (SAS) and Sample Numbering Sheet, as well as the
address of the laboratory, are available on the Biosecurity Queensland Website 
www.biosecurity.qld.gov.au 
• If there are any questions regarding the actual samples, the Biosecurity Sciences Laboratory
(BSL) Laboratory Liaison Officer is contactable on 3708 8762. Suitable courier services to 
consider using for the samples include TOLL, Fastway Couriers or Yellow Couriers. 
• The SAS should specify the species of animal and be marked clearly as ‘Post-bat exposure
vaccination. Paired samples for serology’. Be careful to identify each sample with the date of 
collection and the day relative to vaccination e.g. ‘day 0’ (day of first vaccination), ‘day 28’ (28 
days post first vaccination). 
• The laboratory will forward the serology results to the General Manager, Animal Biosecurity,
for interpretation of the results. This interpretation and a contact phone number will 
accompany the results supplied to the submitting veterinarian by the laboratory as per normal 
practice. 
• The private veterinarian will then be able to pass on the results to the client.
The primary purpose of the serum sampling is to monitor the response to vaccination. The day 0 
serum sample is necessary to allow comparison of titre with the day 28 sample to demonstrate the 
level of response to the vaccine. An appropriate rise in titre between day 0 and day 28 will provide 
a basis for declaring the dog ‘safe’ to stay at home and no longer a risk to others. 
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IMPORTANT: Neither a positive nor a negative titre at day 0 will indicate that the dog or cat is 
either more or less likely to develop clinical ABLV disease. The vaccination schedule still must be 
followed and an elevated titre in the day 28 sample relative to the day 0 sample is still sought. 
Because a positive titre on day 0 has no value in predicting the likelihood of disease, the serum 
samples will be forwarded to AAHL and analysed as paired sera. It follows that this course of  
action will be maintained even in circumstances where the delay in presenting the animal for 
vaccination and sampling on day 0 of the vaccination schedule has been sufficiently long such that 
a positive titre might be reasonably expected if the bat itself had been infected with ABLV. Once a 
period of 60 days has elapsed post vaccination, it is expected that vaccine induced protection will 
prevent disease occurring from that exposure. 
Table 1 Post-exposure prophylaxis program 
First PEP Day 0 • Vaccination with 1ml dose of Nobivac Rabies
consultation Inactivated Rabies Vaccine (intramuscular or 
subcutaneous injection). 
• Microchip animal if not already microchipped.
• Advise BQ of new microchip number by fax.
• Ta ke first blood sample, collect serum, label
and freeze. 
• Advise owner to monitor animal closely for 60
days. 
Second PEP 
consultation 
Day 5 - 7 • Repeat vaccination with 1ml dose of Nobivac
Rabies Inactivated Rabies Vaccine (intramuscular 
or subcutaneous injection) 
Third PEP Day 28 - • Take second blood sample, collect serum,
consultation 35 label and freeze. 
• Send paired sera to a Biosecurity Queensland
laboratory for forwarding to AAHL. 
• Specimen Advice Sheet should be clearly
marked ‘Post-bat exposure vaccination. Paired 
samples for serology’. 
Animals showing clinical signs consistent with ABLV 
Biosecurity Queensland will be responsible for the investigation of animals exhibiting clinical signs 
consistent with ABLV infection. 
Animals exhibiting classical rabies like signs, particularly if the animal is aggressive or 
unmanageable, will be euthanased. Post mortem examination will be conducted to determine the 
cause of the signs. 
Manageable animals may be kept in a secure quarantine facility to allow safe monitoring of clinical 
signs and any testing required. 
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Responsibility for costs 
The owner will be responsible for costs associated with: 
• collecting,and submitting the bat to the laboratory
• the first two PEP consultations
• the rabies vaccine
• microchipping of the animal
• euthanasia of the animal if the owner elects that course of action.
Biosecurity Queensland will cover the following costs: 
• initial testing of the bat/s for ABLV
• the third PEP consultation when the second blood sample is collected
• the transport of the serological samples to the nearest Biosecurity Queensland veterinary
laboratory
• serological tests on the serum samples
• investigation of animals which have had a confirmed exposure to ABLV and exhibit clinical
signs consistent with ABLV infection.
To claim payment from Biosecurity Queensland, please make out a tax invoice to ‘Department of 
Agriculture, Fisheries and Forestry’ and send to: 
Department of Agriculture, Fisheries and Forestry 
Biosecurity Queensland 
Attention - Lawrence Gavey 
PO Box 102 
Toowoomba QLD 4350 
Abbreviations 
AAHL Australian Animal Health Laboratory 
ABLV Australian bat lyssavirus 
APVMA Australian Pesticides and Veterinary Medicines Authority 
BSL Biosecurity Sciences Laboratory 
CVO Chief Veterinary Officer 
CCEAD Consultative Committee on Emergency Animal Diseases 
PEP Post exposure prophylaxis 
Appendix 1 Queensland Health contact numbers 
Public Health Units 
METRO NORTH 
Windsor 3624 1111 
Redcliffe 3142 1800 
METRO SOUTH 
Coopers Plains 3000 9148 
GOLD COAST 
Gold Coast 5668 3700 
WEST MORETON 
Ipswich 3413 1200 
SOUTH WEST 
Charleville 4656 8100 
DARLING DOWNS 
Toowoomba 4631 9888 
SUNSHINE COAST 
Maroochydore 5409 6600 
CENTRAL QUEENSLAND 
Rockhampton 4920 6989 
WIDE BAY 
Hervey Bay 4184 1800 
Bundaberg 4303 7500 
CENTRAL WEST 
Longreach 4658 4700 
NORTH QUEENSLAND 
Cairns and Hinterland 4226 0000 
Mackay 4885 6000 
Mt Isa 4744 4444 
Townsville 4433 1111 
Communicable diseases branch 
3328 9724 or 3328 9728 
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Appendix 2 Application to Chief Veterinary Officer 
For authorisation to use Nobivac rabies inactivated rabies vaccine 
This form can be downloaded from the DAF website. 
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